- Foot problems are common in type-1 and type-2 diabetics
- 20-40% of diabetics have peripheral neuropathy
- Many also have features of peripheral vascular disease
- 15% of diabetics develop foot ulceration
- Diabetes is the leading cause of non-traumatic lower limb amputation
Pathophysiology
- The diabetic foot results from a combination of neuropathy and
ischaemia
- Neuropathy has sensory, motor and autonomic components
- Sensory loss results in loss of protective sensation and unnoticed
foot injuries
- Loss of motor control to the small muscles of the feet results in a
claw foot deformity
- Autonomic neuropathy leads to vasomotor denervation and
arteriovenous shunting
- This compromises the ability to direct blood flow to the capillary
beds
- Ischaemia can affect both the large and small vessels
- Large vessels disease results in atheroma of the femoral, popliteal
and tibial vessels
- Small vessel disease affects the microcirculation
- Other contributing factors include:
- Poor vision
- Limited joint mobility
- Cerebrovascular disease
- Peripheral oedema
- In patients with foot ulceration healing is impaired
- This results from:
- Impaired fibroblast function
- Deficiency in growth factors
- Abnormalities of the extracellular matrix

Management
- Prevention of complications is preferable to the need for active
management
- Patients should be monitored and self-care encouraged
- They should be educated about
- Washing
- Care of cores and calluses
- Toenail cutting
- Suitable footwear
- In those with ulceration assessment should be made of:
- Infection
- Vascular insufficiency

Picture provided by Kevin Varty, Addenbrookes's
Hospital, Cambridge
Management of infection
- Wound swabs often show both gram-negative, gram-positive and
anaerobic bacteria
- Osteomyelitis if usually due to Staph. aureus
- Plain radiography or MRI may demonstrate the extent of the infection
- The threshold for antibiotic use should be low
- The antibiotics used should be based on culture sensitivities
- Surgery may be required if progression despite antibiotic treatment
Management of vascular insufficiency
- All patients with diabetic ulceration should undergo non-invasive
vascular assessment
- The ABPI should be calculated
- This may be falsely elevated due to arterial calcification
- Normal values may still be recorded in diabetics with significant
major vascular disease
- Revascularisation should be considered if arterial insufficiency is
present
- Diabetics have a predisposition for disease in medium-sized vessels
especially at the popliteal trifurcation
- The distal pedal vessels are often spared
- Femoro-distal bypass grafting may be required
Bibliography
Boulton A J, Kirsner R S, Vileikyte L. Neuropathic
diabetic foot ulcers. N Eng J Med 2004; 351:
48-55.
Cavanagh P R, Lipsky B A, Bradbury A W et al.
Treatment for diabetic foot ulcers. Lancet 2005; 36:
1736-1743.
Edmonds M, Foster A. The use of antibiotics in the diabetic
foot. Am J Surg 2004; 187: 25S-28S.
Garapati R, Weinfeld S B. Complex reconstruction of the
diabetic foot and ankle. Am J Surg 2004; 187: 81S
86S.
Gibbons G W. Lower extremity bypass in patients with diabetic
foot ulcers. Surg Clin North Am 2003; 83:
659-669.
Gilbey S G. Neuropathy and foot problems in diabetes.
Clin Med 2004; 4: 318-323.
Jeffcoate W J, Harding K G. Diabetic foot ulcers.
Lancet 2003; 361: 1545-1551.
Lee L, Blume P A, Sumpio B. Charcot joint disease in
diabetes mellitus. Ann Vasc Surg 2003; 17:
571-580.
Reiber G E, Raugi G J. preventing foot ulcers and
amputations in diabetes. Lancet 2005; 366:
1676-1677.
Schweitzer M E, Morrison W B. MR imaging of the diabetic
foot. Radiol Clin North Am 2004; 42: 61-71.
Watkins P J. The diabetic foot. BMJ 2003; 326:
977-979.
|